General Practice Doctors in Mobile, AL Accepting Medicare

10 General Practice doctors found. Showing 1 - 10

Stephen Blaise Chromiak, MD General Practice Medicare: Medicare Enrolled Practice Location: 251 N Bayou St, Mobile, AL 36603 Phone: 251-690-8847    Fax: 251-690-8859

Dr. Kristina Elaine Duffy, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St, Usa Medical Center, Mobile, AL 36617 Phone: 251-471-7117

Dr. Jerome Alexander Ramirez-marquez, MD General Practice Medicare: Medicare Enrolled Practice Location: 2451 University Hospital Dr Rm 714, Mobile, AL 36617 Phone: 251-471-7786

Justin L. Ellerman, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 575 Stanton Rd, Mobile, AL 36617 Phone: 251-471-7207    Fax: 251-471-7468

Charles Franklin Yeager, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 3401 Medical Park Dr, Bldg 1 Ste 102, Mobile, AL 36693 Phone: 251-665-8060    Fax: 251-665-8061

Dr. Louie C. Wilson, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1855 Spring Hill Ave, Mobile, AL 36607 Phone: 251-471-3544    Fax: 251-476-7254

Victor Bowden, General Practice Medicare: Medicare Enrolled Practice Location: 2451 University Hospital Dr, Mobile, AL 36617 Phone: 251-471-7000

Tatiana Carrasquilla, MD General Practice Medicare: Medicare Enrolled Practice Location: 2601 Dauphin Island Pkwy, Mobile, AL 36605 Phone: 251-445-3450

Dr. Kyle Rolfe, DVM General Practice Medicare: Not Enrolled in Medicare Practice Location: 1962 Schillinger Rd S, Mobile, AL 36695 Phone: 251-633-9633

Thomas Walter Irving, MD General Practice Medicare: Medicare Enrolled Practice Location: 3401 Medical Park Dr, Bldg 1 Ste 102, Mobile, AL 36693 Phone: 251-665-8060    Fax: 251-665-8061

News Archive

FDA accepts Tau Therapeutics' mibefradil IND for treatment of cancer

Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that its investigational new drug application (IND 109196) for its novel drug mibefradil has been accepted by the Food and Drug Administration (FDA).

Poll surveys New Year resolutions on weight loss and smoking

Roughly one-third of Americans say they have made a New Year's resolution to lose weight in the last five years and 42 percent of people who said they smoke regularly in that timeframe pledged to quit the habit, according to the Thomson Reuters-NPR Health Poll.

Cheetah Medical closes $20M financing round; plans to expand hemodynamic monitoring market

Cheetah Medical, a worldwide leader in noninvasive hemodynamic and cardiac output monitoring technology, announced today the closing of a $20 million financing round. The financing was led by Ascension Health Ventures (AHV) and also included Robert Bosch Venture Capital (RBVC), MVM Life Science Partners (MVM) and existing investors.

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

One of the key reasons why children are missed by immunization programs, particularly in developing countries where Médecins Sans Frontières (MSF) works, is that the products that we currently have in their present formulation are not well-suited to the places that have the most un-immunized children. These are the most challenging contexts to work in.

Read more Medical News

› Verified 2 days ago